Table of Contents
Definition and Background
Syphilis is a chronic systemic disease that is easily treated in its early stages; however, untreated cases can lead to grave consequences and death. Treponema palladium is the causative factor of syphilis. It was described in 1905 by Schaudinn and Hoffman; Wasserman described the blood test for long-term forms of the infection.
The first outbreak of the illness was noted in 1495, when French soldiers invaded Naples and came down with a deadly disease, which they called “great pox”; much of Europe was devastated by the disease, with thousands of deaths.
During the First World War, syphilis was 1 of the key causes of disability and absence from duty in the United States Army; over 10,000 men were discharged and 7 million person-days were lost to the disease.
The illness has changed names over time; its monikers have included French disease, Spanish fever, and others. After syphilis was first discovered, no effective treatment existed. Because of this, sporadic epidemic outbreaks regularly occurred in different parts of the world.
Mercury was administered by the Esculaps of early medicine as a remedy against this infection; however, this chemical element was extremely toxic and had severe side effects, including death.
Pathogenic treponemes are associated with the following 4 diseases:
- Venereal syphilis, caused by T. pallidum pallidum
- Yaws, caused by T. pallidum pertenue
- Endemic syphilis (bejel), caused by T. Pallidum endemicum
- Pinta, caused by T. carateum
Ways of transmission
- Sexual contact
- Transplacental/congenital syphilis (vertical transmission route; 50%–80% of neonates are exposed to the infection when it is present in the mother)
- Contact with contaminated blood (i.e. transfusion) and tissues
- Personal contact (rare)
Types of syphilis
The Centers for Disease Control and Prevention analyzed data obtained from the National Notifiable Diseases Surveillance System for cases of primary and secondary syphilis diagnosed during 2005–2013 among homosexual, bisexual, and other men having sex with men (MSM). The figure obtained accounted for 5.3 cases per 100,000 population, a number that is twice as high as it was in the period between 2005 and 2013, when it was 2.9 per 100,000.
The highest prevalence was in the western regions of the country. Hispanics were the most affected, at 53.4%, from 1,291 cases in 2009 to 1,980 in 2012; followed by whites at 38.1%, from 2,449 cases in 2009 to 3,381 in 2012; and African Americans at 21.2%, from 2,267 cases in 2009 to 2,747 in 2012. By age group, the greatest percentage increases occurred among MSM aged 25–29 (53.2%, 1,073 cases in 2009 to 1,644 in 2012). Nonwhite women tend to contract syphilis more often than white women (13.3 times to 4 times, respectively).
In the developing world, including sub-Saharan Africa, as well as in Venezuela, syphilis has become a major public health problem. Although the disease has no racial predilection, socioeconomic factors play a pivotal role in its spread. The highest incidence of syphilis is seen in South and Southeast Asia, followed by sub-Saharan Africa and then Latin America and the Caribbean.
Sex: Men contract syphilis more frequently than women. Also, syphilis has a strong affiliation with HIV infection in both drug users and those with a greater number of sexual partners.
Age: Adolescents and young adults who are drug users and have multiple sexual partners are also at risk of infection with TP.
It is vital to take a full history of an affected patient in order to determine the stage of the disease. The history should include a thorough sexual and social history, including the number of sexual partners, condom use, history of sexually transmitted diseases in the patient and their partners, intravenous drug use, and exposure to blood products.
Primary (10–90 days after exposure to the pathogen)
- Hard chancre on genitals
- Painless regional lymphadenopathy
Secondary (4–10 weeks after the first manifestation)
- General: fever, fatigue, pain in joints, sore throat, headache, anorexia, neck stiffness and poly-lymphadenopathy
- Skin: red or brown maculopapular, non-itchy rash
- Mucosa: patches, “snail track” ulcers at the site of T. pallidum penetration
Late stages (tertiary; occur if there is inappropriate treatment or late administration of medication and thus the progression of the disease):
- Late benign: gummas (bone and viscera)
- Heart and vessels: affected aorta (inflammation of the wall and regurgitation)
- Neurosyphilis: meningovascular lesion, paralysis of the insane and tabes dorsalis
Without treatment, symptoms and signs may abate over 3–12 weeks; in 20% of cases, however, symptoms may recur in the early latency period (2 years).
Early stages become apparent between 2 and 6 weeks after birth.
- Stillbirth or retardation of physical and mental development
- “Snuffles”: nasal infection
- Appearance of skin as in secondary syphilis
Late stages become apparent after 2 years of age.
- Stigmata: abnormalities of long bones, sabre tibia
- Hutchinson’s teeth
- Eye problems: keratitis, uveitis, facial gummas
- Central nervous system diseases
- Condyloma acuminata
- Cystitis in women
- Dermatologic manifestations of herpes simplex
- Drug eruptions
- Genital warts
- Granuloma inguinale (donovanosis)
- Herpes zoster
- HIV disease
- Lymphogranuloma venereum
- Urinary tract infection in men
- Urinary tract infections during pregnancy in women
- Varicella-zoster virus
|Stages||Length of exposure to bacterium||
|Secondary syphilis (skin symptoms)||Tertiary syphilis (neurological problems)|
|Time after contact with infected person||Day 1||10–90 days||6 weeks to 6 months||10–30 years|
|Nontreponemal antibody tests: VDRL and RPR. Provide guidance for treatment||Highly informative (sensitive); nontreponemal antibodies are not found after 3 years of adequate treatment.||Same as primary stage||VDRL is performed on CSF and administered in the diagnostics of neurosyphilis.|
|Treponemal antibody tests: FTA-ABS, TP-PA, immunoassays. Proves the nontreponemal antibody test||Specific; followed by nontreponemal antibody test in order to determine active and past infection||Same as primary stage||The CSF FTA-ABS is used for diagnostics of neurosyphilis.|
|Direct detection tests (much less common):|
|Microscopic exam, darkfield exam: a sample taken from the chancre is studied in a special microscopic examination||Detection of the bacteria in the biomaterial||N/A||N/A|
|Polymerase chain reaction (PCR)||Detection of the bacteria in the biomaterial||Genetic material in blood||Detects genetic material in blood and/or CSF sample|
- Computed tomography, as well as magnetic resonance imaging, can detect numerous infarcts in the brain tissue in neurosyphilis.
- X-ray examination is informative when there is a severe lesion of the bones suspected.
- Primary syphilis
- Secondary syphilis
- Late (tertiary) stage
- Quaternary syphilis (extremely rare owing to appropriate medication and diagnostics)
- Early stages
- Late stages
|Stages||First-line treatment||Alternative treatment||Treatment options for pregnant patients||Monitoring|
|Primary, secondary, or early syphilis||Intramuscular benzathine penicillin G 2.4 x 106 U as a single dose||Single 2 g dose of azithromycin (second-line treatment). Azithromycin is contraindicated for homosexual male partners and in pregnancy. Ceftriaxone 1 g daily for 10 days||According to the CDC, pregnant women with a history of allergy should be desensitized and still take penicillin as erythromycin can’t pass the placenta and is not effective.||3, 6, 9, 12, and 24 months|
|Neurosyphilis||Intravenous aqueous penicillin G 4 x 106 U q4 hours or continuous infusion for 10-14 days||Procaine penicillin G 2.4 x 106 U daily with oral probenecid 500 mg qid for 10–14 days. Another option is ceftriaxone 2 g IM or IV daily for 10–14 days.|
|Congenital syphilis||Neonates with normal CSF: intramuscular benzathine penicillin G 50,000 U/kg in a single dose. Neonates with abnormal CSF and babies with CNS involvement: intramuscular aqueous procaine penicillin G 50,000 U/kg/day for 10 days.||3, 6, 9, 12, and 24 months|
Surgical intervention is not required for direct treatment unless there are severe complications that lead to secondary infection of the skin and bone lesions, and tertiary syphilis.